Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
Journal of Biomedicine & Biotechnology
|
May 15, 2010
Chimeric antigen receptor-engineered T cells for immunotherapy of cancer
Marc Cartellieri, Michael Bachmann, Anja Feldmann, et al.
International Journal of Molecular Sciences
|
June 13, 2025
CliniMACS Prodigy Manufacturing of Switchable, AND-Gate CAR T Cells
Alexandra von Jutrzenka-Trzebiatowski, Rutuja Gupte, Cansu Daglar, et al.
Frontiers in Immunology
|
March 31, 2025
A pooled CRISPR screen identifies the Tα2 enhancer element as a driver of <i>TRA</i> expression in a subset of mature human T lymphocytes
Pascal Y Schönberg, Ángela Muñoz-Ovalle, Maciej Paszkowski-Rogacz, et al.
Intervirology
|
February 7, 2007
Reliable generation of stable high titer producer cell lines for gene therapy
Ina Rattmann, Veronika Kleff, Anja Feldmann, et al.
Plos One
|
April 23, 2014
Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8
Irene Michalk, Anja Feldmann, Stefanie Koristka, et al.
International Journal of Molecular Sciences
|
November 25, 2023
Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles
Anja Feldmann, Yvonne Nitschke, Franziska Linß, et al.
The Prostate
|
July 24, 2014
Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells
Claudia Arndt, Anja Feldmann, Katrin Töpfer, et al.
The Prostate
|
May 5, 2011
Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats
Anja Feldmann, Slava Stamova, Claudia C Bippes, et al.
British Journal of Haematology
|
May 24, 2019
Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia
Frederick Fasslrinner, Claudia Arndt, Stefanie Koristka, et al.
Oncotarget
|
June 8, 2018
From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells <i>in vitro</i> and <i>in vivo</i>
Susann Albert, Claudia Arndt, Stefanie Koristka, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
Journal of Biomedicine & Biotechnology
|
May 15, 2010
Chimeric antigen receptor-engineered T cells for immunotherapy of cancer
Marc Cartellieri, Michael Bachmann, Anja Feldmann, et al.
International Journal of Molecular Sciences
|
June 13, 2025
CliniMACS Prodigy Manufacturing of Switchable, AND-Gate CAR T Cells
Alexandra von Jutrzenka-Trzebiatowski, Rutuja Gupte, Cansu Daglar, et al.
Frontiers in Immunology
|
March 31, 2025
A pooled CRISPR screen identifies the Tα2 enhancer element as a driver of <i>TRA</i> expression in a subset of mature human T lymphocytes
Pascal Y Schönberg, Ángela Muñoz-Ovalle, Maciej Paszkowski-Rogacz, et al.
Intervirology
|
February 7, 2007
Reliable generation of stable high titer producer cell lines for gene therapy
Ina Rattmann, Veronika Kleff, Anja Feldmann, et al.
Plos One
|
April 23, 2014
Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8
Irene Michalk, Anja Feldmann, Stefanie Koristka, et al.
International Journal of Molecular Sciences
|
November 25, 2023
Improved Reversion of Calcifications in Porcine Aortic Heart Valves Using Elastin-Targeted Nanoparticles
Anja Feldmann, Yvonne Nitschke, Franziska Linß, et al.
The Prostate
|
July 24, 2014
Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells
Claudia Arndt, Anja Feldmann, Katrin Töpfer, et al.
The Prostate
|
May 5, 2011
Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats
Anja Feldmann, Slava Stamova, Claudia C Bippes, et al.
British Journal of Haematology
|
May 24, 2019
Midostaurin abrogates CD33-directed UniCAR and CD33-CD3 bispecific antibody therapy in acute myeloid leukaemia
Frederick Fasslrinner, Claudia Arndt, Stefanie Koristka, et al.
Oncotarget
|
June 8, 2018
From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells <i>in vitro</i> and <i>in vivo</i>
Susann Albert, Claudia Arndt, Stefanie Koristka, et al.
Page
of 9